Related Experiment Video
Updated: May 4, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Focus on the potential effects of treatments for spondylarthritides on cardiovascular risk
Francesca Ingegnoli1, Roberta Gualtierotti, Carolina Artusi
1Department of Clinical Sciences & Community Health, Division of Rheumatology, University of Milan, 20122 Milan, Italy.
Abstract:
The past years have seen the publication of several studies on seronegative spondylarthritides (SpA) and cardiovascular risk as a result of new insights into the connection between inflammation and atherogenesis. Although the overall cardiovascular disease is a complex entity, chronic inflammation of SpA is known to contribute as an independent risk factor, and new therapies are aimed at reducing this persistent inflammatory status. This review provides an overview of the recent advances in understanding the role of the current therapeutic measures of SpA in preventing or accelerating cardiovascular risk.
Related Concept Videos
Atherosclerosis III: Management
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease IV: Nursing Management
